-
$0
0.0% of portfolio
-
Q2 2025
Added 317.07%
$139M
$140,000
0.0% of portfolio
56,672
Q2 2025
Reduced 26.54%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 19.14%
-
$0
0.0% of portfolio
-
Q2 2025
New
$417M
$2.4 Million
0.0% of portfolio
263,900
Q2 2025
Reduced 36.1%
$689M
$1.88 Million
0.0% of portfolio
46,801
Q2 2025
Added 13.17%
-
$0
0.0% of portfolio
-
Q1 2025
New
$1.65B
$1.64 Million
0.0% of portfolio
24,869
Q2 2025
Reduced 29.12%
$327M
$409,000
0.0% of portfolio
19,536
Q2 2025
Reduced 3.82%
$757M
$6.59 Million
0.0% of portfolio
308,389
Q2 2025
Added 124.27%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 81.21%
$4.43B
$12.3 Million
0.0% of portfolio
74,652
Q2 2025
Reduced 18.23%
$17B
$768,000
0.0% of portfolio
15,853
Q2 2025
Reduced 30.88%
$3.57B
$9.38 Million
0.0% of portfolio
225,191
Q2 2025
Reduced 30.91%
$630M
$1.88 Million
0.0% of portfolio
127,669
Q2 2025
Reduced 12.25%
$4.82B
$6.61 Million
0.0% of portfolio
96,428
Q2 2025
Reduced 20.74%
$503M
$5.63 Million
0.0% of portfolio
550,486
Q2 2025
Reduced 4.02%
-
$0
0.0% of portfolio
-
Q2 2025
Added 46.54%
$272M
$335,000
0.0% of portfolio
270,184
Q1 2025
New
$1.14B
$9.34 Million
0.0% of portfolio
390,632
Q2 2025
Reduced 24.66%
$1.37B
$10 Million
0.0% of portfolio
655,277
Q2 2025
Reduced 8.03%
$6.74B
$11 Million
0.0% of portfolio
388,410
Q2 2025
Reduced 0.41%
Palvella Therapeutics Inc Ne
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.63B
$3.59 Million
0.0% of portfolio
73,434
Q2 2025
Reduced 21.62%
$1.5B
$10.2 Million
0.0% of portfolio
1,670,508
Q2 2025
Added 17.84%
$378M
$585,000
0.0% of portfolio
39,629
Q2 2025
Reduced 34.49%
$186M
$164,000
0.0% of portfolio
16,364
Q2 2025
Reduced 25.04%
$2.4B
$6.24 Million
0.0% of portfolio
610,314
Q2 2025
Reduced 17.19%
$2.72B
$5.6 Million
0.0% of portfolio
33,479
Q2 2025
Reduced 15.13%
$249M
$227,000
0.0% of portfolio
12,726
Q2 2025
Reduced 23.9%
$260M
$511,000
0.0% of portfolio
25,122
Q2 2025
Reduced 17.09%
$8.29B
$8.46 Million
0.0% of portfolio
117,937
Q2 2025
Added 27.12%
$6.57M
$87,000
0.0% of portfolio
57,454
Q2 2025
New
$207M
$179,000
0.0% of portfolio
17,465
Q2 2025
Reduced 28.95%
$2.21B
$3.49 Million
0.0% of portfolio
110,830
Q2 2025
Reduced 17.37%
$2.07B
$3.78 Million
0.0% of portfolio
169,873
Q2 2025
Reduced 46.18%
$531M
$923,000
0.0% of portfolio
31,072
Q2 2025
Reduced 24.85%
$933M
$3.38 Million
0.0% of portfolio
226,840
Q2 2025
Reduced 37.29%
$1.95B
$3.86 Million
0.0% of portfolio
77,130
Q2 2025
Reduced 18.8%
Synchronoss Technologies Inc
-
$0
0.0% of portfolio
-
Q2 2025
New
$2.7B
$5.68 Million
0.0% of portfolio
87,576
Q2 2025
Reduced 15.4%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 54.62%
$831M
$4.24 Million
0.0% of portfolio
1,064,771
Q2 2025
Reduced 16.84%
$231M
$447,000
0.0% of portfolio
95,122
Q2 2025
Reduced 15.93%
$752M
$11.8 Million
0.0% of portfolio
839,004
Q2 2025
Reduced 29.85%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 20.75%
$354M
$741,000
0.0% of portfolio
122,155
Q2 2025
Reduced 18.54%
-
$0
0.0% of portfolio
-
Q2 2025
New
$1.27B
$2.91 Million
0.0% of portfolio
349,837
Q2 2025
Reduced 31.25%
$1.62B
$0
0.0% of portfolio
-
Q2 2025
Reduced 40.68%